Tevogen TVGN
NASDAQ TVGN
$6.59 -0.13 (-1.94%)
As of: Oct 2, 2026 · 9:50 AM EDT

Tevogen (TVGN) Net Equity Issued and Repurchased (2023 - 2026)

Updated

Tevogen's Net Equity Issued and Repurchased came in at $873,702 for Q1 2026, down 56.3% from $2 million a year earlier and down 50.4% from the prior quarter.

Analysis

Tevogen (TVGN) Net Equity Issued and Repurchased (2023 - 2026) Analysis & Trends

Over the trailing twelve months to Mar 31, 2026, Tevogen reported Net Equity Issued and Repurchased of $7.13 million; for FY2025, it was $4.86 million.

  • Net Equity Issued and Repurchased carries a four-year compound annual growth rate of -23.9% (FY2021 to FY2025).
  • Going back by year, Net Equity Issued and Repurchased was $14.5 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Tevogen 27.60 Mn 24.63 Mn - 873,702.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 873,702.00
Dec 31, 2025 1.76 Mn
Mar 31, 2025 2.00 Mn
Mar 31, 2023 2.50 Mn
API Access

Tevogen Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=TVGN&period=max&api_key=YOUR_API_KEY